Allspring Global Investments Holdings, LLC
Position in NBIX — Neurocrine Biosciences Inc
CIK 1890906
CHARLOTTE, NC
Position in NBIX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$50,518,346
+$6,726,918 QoQ
Shares Held
299,741
-9.8% QoQ
Ownership
0.295%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#61
of 768 holders
Holding Since
Dec 2021
17 quarters on record
Voting authority
Sole 25%
Shared 0%
None 75%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Allspring Global Investments Holdings, LLC holds $368,259,711 across 23 Drug Manufacturers - Specialty & Generic names. NBIX ranks #5 (13.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ELAN |
Elanco Animal Health Inc
|
2,791,143 | $68,690,028 | |
| 2 | PBH |
Prestige Consumer Healthcare Inc.
|
1,271,950 | $60,125,075 | |
| 3 | AMRX |
Amneal Pharmaceuticals, Inc.
|
3,295,533 | $57,045,674 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
96,696 | $52,392,792 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
This page
|
299,741 | $50,518,346 | |
| 6 | TEVA |
Teva Pharmaceutical Industries Ltd
|
1,458,911 | $49,427,903 | |
| 7 | PAHC |
Phibro Animal Health Corp
|
254,234 | $7,982,947 | |
| 8 | INDV |
Indivior Pharmaceuticals, Inc.
|
112,438 | $4,613,330 |
All Filings in NBIX
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $50,518,346 | 299,741 | Shares | Other | 2026-08-13 | |
| 2026-03-31 | $43,791,428 | 332,408 | Shares | Other | 2026-05-05 | |
| 2025-12-31 | $48,141,639 | 339,432 | Shares | Other | 2026-01-15 | |
| 2025-09-30 | $53,687,066 | 382,441 | Shares | Other | 2025-10-20 | |
| 2025-06-30 | $56,296,550 | 447,900 | Shares | Other | 2025-07-25 | |
| 2025-03-31 | $42,891,342 | 387,806 | Shares | Other | 2025-04-24 | |
| 2024-12-31 | $65,597,122 | 480,565 | Shares | Other | 2025-01-29 | |
| 2024-09-30 | $79,500,185 | 689,986 | Shares | Defined | 2024-10-18 | |
| 2024-06-30 | $97,828,301 | 710,600 | Shares | Defined | 2024-07-26 | |
| 2023-12-31 | $54,035,170 | 410,103 | Shares | Defined | 2024-01-25 | |
| 2023-09-30 | $25,362,337 | 225,443 | Shares | Defined | 2023-10-27 | |
| 2023-06-30 | $34,853,656 | 369,604 | Shares | Defined | 2023-07-18 | |
| 2023-03-31 | $34,213,776 | 338,014 | Shares | Defined | 2023-04-13 | |
| 2022-12-31 | $59,265,291 | 496,193 | Shares | Defined | 2023-01-23 | |
| 2022-09-30 | $57,251,332 | 539,039 | Shares | Defined | 2022-10-26 | |
| 2022-06-30 | $10,953,242 | 112,364 | Shares | Defined | 2022-07-25 | |
| 2021-12-31 | $17,465,471 | 205,066 | Shares | Defined | 2022-01-28 | |
| No filing history on record for this holder in this stock. | ||||||